Pharmaburst® 500

Pharmaburst® was the first orally disintegrating tablet (ODT) platform on the market. Pharmaburst 500 is the current standard for its performance and versatility. It is an ideal choice among formulators because it addresses development challenges and creates premium products. It is a co-processed excipient platform meeting globally accepted compendia and is used in over 60 commercialized products worldwide.

Orally Disintegrating Tablet Platform
Pharmaburst 500 produces fast disintegrating tablets that are hard enough to withstand the mechanics of production, storage, transportation, and being pushed out of a blister pack, yet will disintegrate rapidly so the patient can swallow their medication comfortably.

Simplify your formulation and manufacturing process while streamlining your path to market.

Patient Compliance

Rapid disintegration time of 30 seconds or less, crucial for patient compliance

Excellent mouthfeel qualities to help improve patient compliance- making your drug product more successful

Better Drug Loading Capability

Highly compactible- carry high drug loads without increased tablet size

Robust Tablets

Manufacture durable tablets at lower compression forces

Reduce stress on equipment and multiparticulates while ensuring the integrity of the coat is maintained

Ease of Manufacturing

Pharmaburst 500 is designed to be a completely optimized platform that requires little formulation development. Orally disintegrating tablets formulated with Pharmaburst are also easy to manufacture using standard direct compression equipment and processes. Simply add the active, dry blend, and compress.

Related Product Information

Related Applications

Orally Disintegrating Technology (Oral Drug Delivery)

Orally Disintegrating Technology (Oral Drug Delivery)

Offering ease of use and convenience, orally disintegrating tablets (ODT) and powders (ODP) have become a preferred dosage form for consumers worldwide for medications in a variety of therapeutic areas.

Safety Data Sheet

Related Videos

Contact our Experts Today

Learn how SPI Pharma and Q-Vant can enhance access to Saponin based Adjuvants and enhance your vaccine development.  Contact us to discuss your developments with our experts